目的:观察鞘内注射P2Y12受体抑制剂MRS2395对骨癌痛大鼠痛阈及其脊髓炎症因子表达的影响,探讨P2 Y12受体与炎症因子在骨癌痛发病机制中的可能作用。方法雌性SD大鼠32只,随机数字表法随机分为4组:假手术组( S组)、MRS2395组( M组)、胫骨癌痛组( A组)、胫骨癌痛MRS2395组( MA组)。 S组、M组左胫骨上端骨髓腔各注入Hank′s液10μl,A组、MA组左胫骨上端骨髓腔各注入Walker256癌细胞悬液10μl。骨癌痛造模同时均进行L3-4间隙鞘内置管,模型制备成功后第9~12天, S 组、A 组鞘内注射0.9%生理盐水15μl/d, M 组、MA 组鞘内注射 MRS2395(400 pmol/μl)15μl/d。术后第9~12天鞘内注药前、后每10分钟测试1次大鼠左后足机械痛阈值,术后第12天鞘内注药测定机械痛阈值后,取L4-L6左侧脊髓背角,采用酶联免疫吸附测定法测脊髓炎症因子IL-1β、IL-6的表达情况。结果建模后第9天,S组、M组、A组、MA组给药后20 min机械痛阈值分别为(34.2±5.8)g、(34.4±5.7)g、(21.0±2.0)g、(25.4±2.3)g,差异有统计学意义(F=18.679,P<0.01);与S组、M组比较,A组机械痛阈值下降;与A组比较,MA组机械痛阈值增高。建模后第12天,S组、M组、A组、MA组大鼠脊髓IL-1β含量分别为(74.0±18.6)pg/ml、(98.4±17.3) pg/ml、(253.5±66.4)pg/ml、(146.3±22.3) pg/ml,差异有统计学意义(F=18.221,P<0.01);与S组、M组比较,A组大鼠脊髓IL-1β含量明显升高;S组、M组、A组、MA组大鼠脊髓IL-6含量分别为(377.4±65.8)pg/ml、(331.6±67.9) pg/ml、(856.1±53.4) pg/ml、(596.1±34.9) pg/ml,差异有统计学意义(F=70.880,P<0.01);与S组、M组比较,A组大鼠脊髓IL-6含量明显升高;与A组比较, MA组大鼠鞘内注射MRS2395后IL-1β和IL-6含量均明显降低。结论鞘内注射MRS2395可缓解骨癌痛大鼠的痛觉过敏,抑制骨癌?
Objective To explore the roles of P2Y12 receptor ( P2Y12R) in bone cancer pain by observing the changes of inflammatory cytokines (IL-1β, IL-6) after intrathecal injection (i.t.) of P2Y12R antagonist MRS2395.Methods Thirty-two female SD rats were randomly divided into 4 groups ( n =8 each):sham group (group S), MRS2395 group (group M), cancer group (group A) and cancer +MRS2395 group ( group MA).Groups S and M received an injection of 10 μl Hank′s solution into left tibia medullar cavity while groups A and MA had an injection of Walker 256 mammary cancer cells (10 μl, 2 × 107 cells/ml) into the same place.At Day 9-12 post-inoculation, groups S and A received an injection of saline (0.9%, 15 μl, i.t.) while groups M and MA had MRS2395 (400 pmol/μl, 15 μl, i.t.).Intrathecal catheterization between L 3 and L4 was performed immediately after inoculating tumor cells by inserting a small tube into vertebral space.Mechanical withdrawal thresholds were measured on left hind paws before and during 10-minute intervals after dosing.Spinal cords ( L4-L6 segments ) were removed for determining the expressions of IL-1βand IL-6 by enzyme-linked immunosorbent assay ( ELISA ) at Day 12 after drug delivery.Results At 20 min post-injection, mechanical withdrawal thresholds of groups S , M, A and MA were (34.2±5.8), (34.4 ±5.7), (21.0 ±2.0) and (25.4 ±2.3) g respectively at Day 9 post-inoculation ( F=18.679, P〈0.01 ); mechanical withdrawal thresholds of group A obviously decreased versus groups S and M;mechanical withdrawal thresholds in group MA increased obviously versus group A.The expressions of IL-1βin groups S , M, A and MA were ( 74.0 ±18.6 ) , ( 98.4 ±17.3 ) , ( 253.5± 66.4) and (146.3±22.3) pg/ml at Day 12 post-inoculation (F=18.221, P〈0.01); compared with groups S and M, the expression of IL-1βin group A showed a significant up-regulation.Likewise, the expressions of IL-6 were (377.4 ±65.8), ?